Related Experiment Video
Updated: Jun 10, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Cyclophosphamide for rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation
Ido Paz-Priel1, David W Cooke, Allen R Chen
1Division of Pediatric Oncology, Johns Hopkins University, Baltimore, MD 21231, USA. ipazpri1@jhmi.edu
Abstract:
Patients with rapid-onset obesity, hypothalamic dysfunction, hypoventilation, autonomic dysregulation, and neural crest tumor syndrome have poor long-term outcomes. We report a patient who was treated successfully with high-dose cyclophosphamide immunoablation. This experience offers a novel therapeutic approach and an indirect insight into the underlying pathogenesis of this syndrome.
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Drug Dosing: Obese Patients
Cushing Syndrome II: Pathophysiology
Hypoglycemia and Glucagon
Hyperosmolar Hyperglycemic State
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
